Loading…
Healthpeak Properties, Inc. is projected to rise to $24.52 by 2027, a +13% move from its current price of $21.65. DOC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $21.38 | $21.65 | $21.93 | +0.02% |
| Jul 15 | $21.27 | $21.66 | $22.05 | +0.04% |
| Jul 16 | $21.19 | $21.66 | $22.15 | +0.06% |
| Jul 17 | $21.12 | $21.67 | $22.23 | +0.08% |
| Jul 18 | $21.06 | $21.67 | $22.30 | +0.10% |
| Jul 19 | $21.01 | $21.68 | $22.36 | +0.12% |
| Jul 20 | $20.96 | $21.68 | $22.42 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.96 | $21.68 | $22.42 | +0.14% |
| Week 2 | $20.70 | $21.71 | $22.77 | +0.29% |
| Week 3 | $20.51 | $21.74 | $23.05 | +0.43% |
| Week 4 | $20.35 | $21.77 | $23.29 | +0.57% |
| Week 5 | $20.22 | $21.80 | $23.51 | +0.72% |
| Week 6 | $20.10 | $21.84 | $23.72 | +0.86% |
| Week 7 | $20.00 | $21.87 | $23.91 | +1.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. The company is organized as an umbrella partnership REIT and was incorporated in 1985 in Maryland, USA.
Healthpeak OP is a consolidated subsidiary through which we conduct our operations, and we are the managing member of that subsidiary.
Healthpeak maintains a diversified portfolio across three core asset classes: Outpatient medical, Lab, and continuing care retirement community (CCRC) real estate. As of September 30, 2025, the portfolio consisted of interests in 703 properties (Outpatient medical – 530 properties; Lab – 139 properties; CCRC – 15 properties; Other non-reportable – 19 properties). Under the outpatient medical and lab segments we own, operate, and develop outpatient medical buildings, hospitals, and lab facilities, while CCRC properties are operated through RIDEA structures.
This portfolio also includes an interest in an unconsolidated joint venture that owns 19 senior housing assets, loans receivable, and a preferred equity investment.
Headquartered in Denver, Colorado, Healthpeak has additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices across the United States. We are a Maryland corporation and qualify as a self-administered REIT, operating through Healthpeak OP, a consolidated subsidiary.
Healthpeak Properties, Inc. (ticker: DOC) is a Real Estate company with a current price of $21.23 and a market capitalization of $14.64B, ranking 726 by size. The stock sits within a healthcare-focused real estate niche with a broad property footprint across outpatient medical, lab, and CCRC real estate.
The near-term technical picture is bullish, with RSI4 at 70 and the stock trading above key moving averages. The 50-day simple moving average is $18.84 and the 200-day simple moving average is $17.81, providing a positive longer-term tilt. Near-term support is at $19.00 and resistance at $21.23.
The 30-day price range spans from $19.22 to $23.44, and the stock shows about 30% annualized volatility.
Looking ahead, the forecast depicts a rising price path with year-by-year averages and ROIs, including 2026 where the avg is $21.23 and ROI is 0%, progressing to higher levels in subsequent years, with notable targets at 2030, 2040 and 2050.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 12.2% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 9.9% above — clearing it would confirm fresh momentum.
Key DOC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DOC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.73 | Sell | $21.67 | Sell |
| MA 10 | $21.70 | Sell | $21.53 | Buy |
| MA 20 | $21.01 | Buy | $21.10 | Buy |
| MA 50 | $19.85 | Buy | $20.01 | Buy |
| MA 100 | $18.42 | Buy | $19.04 | Buy |
| MA 200 | $17.98 | Buy | $18.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.29 | Neutral |
| Stoch RSI (14) | 40.86 | Neutral |
| CCI (20) | 59.75 | Neutral |
| Williams %R (14) | -14.36 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 5.30 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 85.64 | Sell |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 1.27 | Buy |
| Ultimate (7,14,28) | 65.31 | Neutral |
| Momentum (10) | 0.42 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 21.71 | Sell |
| ADX (14) | 28.33 | Buy |
| ATR (14) | 0.26 | Info |
The 30-day technical picture shows a bullish tilt, with RSI at 70 indicating strong relative strength. The stock is trading above the 50-day SMA of $18.84 and the 200-day SMA of $17.81, suggesting a positive intermediate-term trajectory.
Within the near term, the price has moved in a range between $19.22 and $23.44 over the last 30 days, placing the current price of $21.23 inside that band. Support sits at $19.00 and resistance at $21.23, providing defined levels to monitor for near-term action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.99 | $21.65 | $27.26 | 0% | Neutral | |
| $20.08 | $24.52 | $31.29 | +13% | Neutral | |
| $21.75 | $27.05 | $35.47 | +25% | Bullish | |
| $23.54 | $29.74 | $39.82 | +37% | Bullish | |
| $27.29 | $34.93 | $47.62 | +61% | Bullish | |
| $32.70 | $42.37 | $58.66 | +96% | Bullish | |
| $34.74 | $45.52 | $63.93 | +110% | Bullish | |
| $36.18 | $47.92 | $68.16 | +121% | Bullish | |
| $38.08 | $50.93 | $73.32 | +135% | Bullish | |
| $39.30 | $53.06 | $77.23 | +145% | Bullish | |
| $59.97 | $84.44 | $128.80 | +290% | Bullish | |
| $118.84 | $179.47 | $293.45 | +729% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $15.99 | $21.65 | $25.73 | +0.00% |
| August 2026 | $18.50 | $21.65 | $25.89 | +0.02% |
| September 2026 | $18.75 | $22.06 | $26.58 | +1.86% |
| October 2026 | $19.06 | $22.51 | $27.31 | +2.07% |
| November 2026 | $18.80 | $22.28 | $27.18 | -1.01% |
| December 2026 | $18.70 | $22.23 | $27.26 | -0.23% |
Click any year to see its month-by-month DOC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DOC is projected to trade between $15.99 and $27.26, averaging $21.65 — a potential gain of 0% from today's $21.65. A consolidation phase looks the most probable path here.
Healthpeak Properties, Inc.'s 2027 outlook centres on $24.52, within a $20.08 to $31.29 range. That is up +13% on the projected 2026 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2028, DOC could reach as high as $35.47, with a base case around $27.05 and support toward $21.75 — roughly +25% from $21.65. Buyers look set to stay in control over this stretch.
Expect DOC to range from $23.54 to $39.82 through 2029. The $29.74 average target implies a +37% move from current prices. That is up +10% on the projected 2028 average. Momentum favours further upside here.
The DOC price prediction for 2030 points to an average of $34.93 (low $27.29, high $47.62) — a potential gain of +61% on today's $21.65. Buyers look set to stay in control over this stretch.
In 2031, DOC is projected to trade between $32.70 and $58.66, averaging $42.37 — a potential gain of +96% from today's $21.65. That is up +21% on the projected 2030 average. Momentum favours further upside here.
Healthpeak Properties, Inc.'s 2032 outlook centres on $45.52, within a $34.74 to $63.93 range. That is up +7% on the projected 2031 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DOC could reach as high as $68.16, with a base case around $47.92 and support toward $36.18 — roughly +121% from $21.65. Momentum favours further upside here.
Expect DOC to range from $38.08 to $73.32 through 2034. The $50.93 average target implies a +135% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DOC price prediction for 2035 points to an average of $53.06 (low $39.30, high $77.23) — a potential gain of +145% on today's $21.65. Momentum favours further upside here.
In 2040, DOC is projected to trade between $59.97 and $128.80, averaging $84.44 — a potential gain of +290% from today's $21.65. That is up +59% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Healthpeak Properties, Inc.'s 2050 outlook centres on $179.47, within a $118.84 to $293.45 range. That is up +113% on the projected 2040 average. That marks a +729% change versus current levels. Momentum favours further upside here.
Investing $1,000 in DOC today (≈ 46.189376 DOC) could be worth
$8,289.7
+$7,289.7 (+729%) by 2050 · US Dollar
Based on the average projected DOC price of $179.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DOCwould be worth at today's price.
$1,000 invested in DOC on Jul 10, 2025 (≈ 53.93743 DOC) would be worth
$1,167.75
+$167.75 (+16.8%) today · 1.17× · US Dollar
Based on a DOC entry price of $18.54 vs. today's $21.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.89 | $989.04 | -1.1% |
| 1 month ago | $20.47 | $1,057.65 | +5.8% |
| 3 months ago | $16.74 | $1,293.31 | +29.3% |
| 6 months ago | $16.81 | $1,287.92 | +28.8% |
| 1 year ago | $18.54 | $1,167.75 | +16.8% |
| All time (5.0y) ago | $34.97 | $619.1 | -38.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DOC forecast.
Our base-case forecast reaches $43.00 around 2032.
Implied market cap at $43.00: $29.65B
The multi-year forecast shows persistent upside through the horizon, with the 2030 avg price projected at $35.55 and a max of $48.50 (min $27.76) and an ROI of 67.5%, signaling bullish momentum. The 2040 forecast envisions an avg of $86.15 (min $61.16, max $131.45) with an ROI of 305.8% and a bullish sentiment. By 2050, the avg price is projected at $188.37 (min $124.69, max $308.08) and an ROI of 787.3%, continuing the bullish trajectory.
These figures imply substantial upside if the projected paths materialize, but they are estimates and not guarantees. Market conditions, rates, and other factors can influence outcomes.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $35.55, with a min of $27.76 and a max of $48.50, and an ROI of 67.5%, with a bullish sentiment.
The forecast shows a rising average price path through 2035 and beyond, with 2030 at $35.55, 2040 at $86.15, and 2050 at $188.37, corresponding to ROIs of 67.5%, 305.8%, and 787.3% respectively, all with bullish sentiment. These are estimates, not guarantees.
Yes. The 2030 max is $48.50, and the 2031 max is $58.90, indicating it could exceed $50 in 2031 according to the forecast.
The 30-day range is $19.22 to $23.44.
Current price is $21.23 and market capitalization is $14.64B.
Healthpeak Properties, Inc. Community Discussion
0Share your Healthpeak Properties, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.